Motivated To Lead Podcast - Mark Klingsheim

This week, we revisit our interview with John Milad. John has 25 years of experience as a start-up executive, venture investor, and banker specializing in healthcare innovation across the UK, Europe, and the US. He had 10 years of life sciences venture experience at a family office, Atlas Venture, NBGI Venture and Downing. Notable exits include Symetis, ACT/EPIX, BoneSupport and Medcast/WebMD. John is a Co-founder of Quanta Dialysis Technologies, which I led as CEO for 8 years. Notable outcomes include creating an award-winning, disruptive portable dialysis system; raising nearly $400m in funding; commercially launching in UK and US; and establishing trans-Atlantic commercial operations. For another 2 years, he served as an executive at Nitec Pharma, which was ultimately sold to Horizon Therapeutics. John has held multiple board positions across the sector. He has been an advisor to NIIR/I4i programme, mentor at the Enterprise Hub of the Royal Academy of Engineering.  He has been recognized in the Sunday